From the Star Tribune:
'Middle Ground Solution' Bill by Coleman Approved
Thursday, April 12, 2007 at 8:25 AM
WASHINGTON - With Sen. Amy Klobuchar's support, Sen. Norm Coleman, R-Minn., marked a victory Wednesday when his embryonic stem cell legislation passed the Senate just after senators approved another stem cell measure President Bush promises to veto.
The bill Coleman co-sponsored limits federally funded embryonic stem cell research to stem cells those derived from "naturally dead" embryos, and it was approved 70 to 28.
Coleman called his bill a "middle ground solution" and said it moves scientific research forward without destroying embryos.
Read the whole article Here.
Norm Coleman's bill is NOT a middle ground solution. Norm was taking his marching orders from the extremists at the FRC. People should call Amy Klobuchar and Norm Coleman and let them know what you think. The FRC claims of successful adult stem cell research have been rebutted in Science Magazine:
Originally published in Science Express on 13 July 2006
Science 28 July 2006:
Vol. 313. no. 5786, p. 439
Prev | Table of Contents | Next
Adult Stem Cell Treatments for Diseases?
Opponents of research with embryonic stem (ES) cells often claim that adult stem cells provide treatments for 65 human illnesses. The apparent origin of those claims is a list created by David A. Prentice, an employee of the Family Research Council who advises U.S. Senator Sam Brownback (R-KS) and other opponents of ES cell research (1).
Prentice has said, "Adult stem cells have now helped patients with at least 65 different human diseases. It's real help for real patients" (2). On 4 May, Senator Brownback stated, "I ask unanimous consent to have printed in the Record the listing of 69 different human illnesses being treated by adult and cord blood stem cells" (3).
In fact, adult stem cell treatments fully tested in all required phases of clinical trials and approved by the U.S. Food and Drug Administration are available to treat only nine of the conditions on the Prentice list, not 65 [or 72 (4)]. In particular, allogeneic stem cell therapy has proven useful in treating hematological malignancies and in ameliorating the side effects of chemotherapy and radiation. Contrary to what Prentice implies, however, most of his cited treatments remain unproven and await clinical validation. Other claims, such as those for Parkinson's or spinal cord injury, are simply untenable.
The references Prentice cites as the basis for his list include various case reports, a meeting abstract, a newspaper article, and anecdotal testimony before a Congressional committee. A review of those references reveals that Prentice not only misrepresents existing adult stem cell treatments, but also frequently distorts the nature and content of the references he cites (5).